We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-2.49%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$12.8B
AUM Growth
-$896M
Cap. Flow
-$396M
Cap. Flow %
-3.08%
Top 10 Hldgs %
24.99%
Holding
3,035
New
97
Increased
329
Reduced
999
Closed
146

Sector Composition

Rank Sector Weight
1 Technology 25.12%
2 Healthcare 12.03%
3 Financials 11.49%
4 Consumer Discretionary 10.97%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SITE icon
2051
SiteOne Landscape Supply
SITE
$4.27B
$241K ﹤0.01%
1,477
+1
+0.1% +$163
ACRS icon
2052
Aclaris Therapeutics
ACRS
$863M
$241K ﹤0.01%
35,160
SRDX
2053
DELISTED
Surmodics
SRDX
$241K ﹤0.01%
7,505
NTNX icon
2054
Nutanix
NTNX
$18.4B
$240K ﹤0.01%
6,878
+6
+0.1% +$188
SPCE icon
2055
Virgin Galactic
SPCE
$475M
$240K ﹤0.01%
6,660
FWONK icon
2056
Liberty Media Series C
FWONK
$26B
$240K ﹤0.01%
3,847
-126
-3% -$8.65K
LAND
2057
Gladstone Land Corp
LAND
$358M
$239K ﹤0.01%
16,827
SWI
2058
DELISTED
SolarWinds Corporation Common Stock
SWI
$239K ﹤0.01%
25,312
WSR
2059
DELISTED
Whitestone REIT
WSR
$239K ﹤0.01%
24,790
PGC icon
2060
Peapack-Gladstone Financial
PGC
$822M
$238K ﹤0.01%
9,287
RNAM
2061
DELISTED
Avidity Biosciences
RNAM
$238K ﹤0.01%
37,333
MLNK
2062
DELISTED
MeridianLink
MLNK
$238K ﹤0.01%
13,959
CRCT icon
2063
Cricut
CRCT
$1.24B
$238K ﹤0.01%
25,580
AVXL icon
2064
Anavex Life Sciences
AVXL
$303M
$237K ﹤0.01%
36,249
BFST icon
2065
Business First Bancshares
BFST
$1.05B
$237K ﹤0.01%
12,639
DCGO icon
2066
DocGo
DCGO
$64.5M
$236K ﹤0.01%
44,276
DMRC icon
2067
Digimarc Corp
DMRC
$158M
$235K ﹤0.01%
7,240
-1,225
-14% -$39.2K
USLM icon
2068
United States Lime & Minerals
USLM
$3.37B
$235K ﹤0.01%
5,835
HVT icon
2069
Haverty Furniture Companies
HVT
$450M
$234K ﹤0.01%
8,136
IIIV icon
2070
i3 Verticals
IIIV
$325M
$234K ﹤0.01%
11,069
MDT icon
2071
Medtronic
MDT
$116B
$233K ﹤0.01%
2,977
-334,671
-99% -$28M
APLS
2072
DELISTED
Apellis Pharmaceuticals
APLS
$233K ﹤0.01%
6,128
+2
+0% +$88
TXG icon
2073
10x Genomics
TXG
$7.58B
$233K ﹤0.01%
5,642
+3
+0.1% +$156
CENT icon
2074
Central Garden & Pet Co
CENT
$2.78B
$232K ﹤0.01%
6,570
AVO icon
2075
Mission Produce
AVO
$1.15B
$232K ﹤0.01%
23,931

Similar funds

MetLife Investment Management's Q3 2023 Portfolio in Review

As of Q3 2023, MetLife Investment Management held 3,035 positions worth $12.8B, down 6.5% from $13.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management withdrew a net $396M in Q3 2023, closing 146 positions and reducing 999 holdings. Its most notable exit was Accenture, an estimated $57.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Kenvue worth $9.06M.

  • MetLife Investment Management's largest Q3 2023 buy was Kenvue: 451,001 shares worth $9.06M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $37.9M increase.
  • MetLife Investment Management's biggest Q3 2023 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $125M.
  • MetLife Investment Management fully exited Accenture in Q3 2023, selling an estimated $57.6M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $12.8B portfolio in Q3 2023.
  • MetLife Investment Management opened 97 new positions and closed 146 in Q3 2023.
  • MetLife Investment Management's portfolio value fell 6.5% quarter-over-quarter to $12.8B.

Based on MetLife Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.